Designed to be attached to a smartphone's camera, HÜD captures medical-grade images of suspicious spots, and when used in conjunction with First Derm's app – it allows users to remotely evaluate potentially deadly skin cancer lesions. Users simply take photos and keep track of moles with images, and share suspicious ones with a dermatologist for evaluation.
"We're empowering the consumer to take proactive steps towards early detection of skin cancer with the power of mobile technology," says Dr. Alexander Börve, CEO of First Derm, whom we had a chance to interview earlier this year.
HÜD captures medical-grade images of suspicious spots, allowing users to remotely evaluate potentially deadly skin cancer lesions.HÜD is First Derm's joint venture product with Dermlite, which brings nearly two decades of hardware refinement to the mix.
The Indiegogo campaign offers the early bird prices of $65 for the first 50 devices sold. Once it hits the retail, HÜD is expected to sell for $79.99.
Other perks include behind-the-scenes insider access and a meet-and-greet with the design team. Check it out.